Loading…
Early Phosphorylation Events Induced by DPIV/CD26-Specific Inhibitors
Dipeptidyl peptidase IV (DPIV, CD26) is known to be involved in the regulation of T lymphocyte and NK cell activation and proliferationin vitro.The molecular events of lymphocyte activation mediated by this ectopeptidase as well as their physiological ligands are only partly established. Particularl...
Saved in:
Published in: | Cellular immunology 1998-10, Vol.189 (1), p.60-66 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83 |
---|---|
cites | cdi_FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83 |
container_end_page | 66 |
container_issue | 1 |
container_start_page | 60 |
container_title | Cellular immunology |
container_volume | 189 |
creator | Kähne, Thilo Neubert, Klaus Faust, Jürgen Ansorge, Siegfried |
description | Dipeptidyl peptidase IV (DPIV, CD26) is known to be involved in the regulation of T lymphocyte and NK cell activation and proliferationin vitro.The molecular events of lymphocyte activation mediated by this ectopeptidase as well as their physiological ligands are only partly established. Particularly, the necessity of catalytic dipeptidase activity for the costimulatory function of this molecule has been controversial. Here we provide evidence for a direct involvement of DPIV/CD26 in early phosphorylation mechanisms which are known to be essential in the signal transduction cascade of human T lymphocytes. We have found that DPIV-specific inhibitors (Lys[Z(NO2)]-thiazolidide and -piperidide) are capable of inducing intracellular tyrosine phosphorylation in resting human T cells. On the other hand, both inhibitors decreased the PMA-induced tyrosine phosphorylation in human T cells in a dose-dependent manner. Furthermore, a linkage between CD26 and the tyrosine kinase p56lckwas shown by inhibition of PMA-induced hyperphosphorylation of p56lckby means of DPIV-specific inhibitors. The data presented here suggest that the inhibition of DPIV enzymatic activity induces a inhibitory signal transmitted by tyrosine kinases which leads to a block in a PMA-induced downstream pathway. These results support the assumption that DPIV/CD26 is directly involved in early processes of T cell activation via its enzymatic activity. |
doi_str_mv | 10.1006/cimm.1998.1355 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17106860</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0008874998913557</els_id><sourcerecordid>17106860</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83</originalsourceid><addsrcrecordid>eNp1kDtPwzAUhS0EKqWwsiFlYkt6nYdjj6gtUKkSlXislmPfqEZ5FDup1H9PolZsTHf4zjnS_Qi5pxBRADbXtq4jKgSPaJJlF2RKQUAYU5ZckikA8JDnqbgmN95_A1CaCpiQicgzzkQ2JauVctUx2O5av9-17lipzrZNsDpg0_lg3ZheowmKY7Dcrr_mi2XMwvc9altaPdCdLWzXOn9LrkpVebw73xn5fF59LF7DzdvLevG0CXWSQxdmseYlJEmmDC0KxYxBXVAwKU-R5bQsUhQMMY2Z1oaWJheYK0h4xlic5oonM_J42t279qdH38naeo1VpRpsey9pToFxBkMwOgW1a713WMq9s7VyR0lBjt7k6E2O3uTobSg8nJf7okbzFz-LGjg_cRzeO1h00muLzSDHOtSdNK39b_oXAlV72A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17106860</pqid></control><display><type>article</type><title>Early Phosphorylation Events Induced by DPIV/CD26-Specific Inhibitors</title><source>Elsevier</source><creator>Kähne, Thilo ; Neubert, Klaus ; Faust, Jürgen ; Ansorge, Siegfried</creator><creatorcontrib>Kähne, Thilo ; Neubert, Klaus ; Faust, Jürgen ; Ansorge, Siegfried</creatorcontrib><description>Dipeptidyl peptidase IV (DPIV, CD26) is known to be involved in the regulation of T lymphocyte and NK cell activation and proliferationin vitro.The molecular events of lymphocyte activation mediated by this ectopeptidase as well as their physiological ligands are only partly established. Particularly, the necessity of catalytic dipeptidase activity for the costimulatory function of this molecule has been controversial. Here we provide evidence for a direct involvement of DPIV/CD26 in early phosphorylation mechanisms which are known to be essential in the signal transduction cascade of human T lymphocytes. We have found that DPIV-specific inhibitors (Lys[Z(NO2)]-thiazolidide and -piperidide) are capable of inducing intracellular tyrosine phosphorylation in resting human T cells. On the other hand, both inhibitors decreased the PMA-induced tyrosine phosphorylation in human T cells in a dose-dependent manner. Furthermore, a linkage between CD26 and the tyrosine kinase p56lckwas shown by inhibition of PMA-induced hyperphosphorylation of p56lckby means of DPIV-specific inhibitors. The data presented here suggest that the inhibition of DPIV enzymatic activity induces a inhibitory signal transmitted by tyrosine kinases which leads to a block in a PMA-induced downstream pathway. These results support the assumption that DPIV/CD26 is directly involved in early processes of T cell activation via its enzymatic activity.</description><identifier>ISSN: 0008-8749</identifier><identifier>EISSN: 1090-2163</identifier><identifier>DOI: 10.1006/cimm.1998.1355</identifier><identifier>PMID: 9758695</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Calcium - metabolism ; CD26 ; CD3 Complex - metabolism ; Cyclic AMP - metabolism ; Dipeptidyl Peptidase 4 - metabolism ; dipeptidyl peptidase IV ; Humans ; Lymphocyte Specific Protein Tyrosine Kinase p56(lck) - metabolism ; Lysine - analogs & derivatives ; Lysine - pharmacology ; Mitogens - pharmacology ; Phosphorylation ; Piperidines - pharmacology ; Protease Inhibitors - pharmacology ; Protein Kinase C - metabolism ; protein tyrosine phosphorylation ; T-Lymphocytes - metabolism ; Tetradecanoylphorbol Acetate - pharmacology ; Thiazoles - pharmacology ; Tyrosine - metabolism</subject><ispartof>Cellular immunology, 1998-10, Vol.189 (1), p.60-66</ispartof><rights>1998 Academic Press</rights><rights>Copyright 1998 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83</citedby><cites>FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9758695$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kähne, Thilo</creatorcontrib><creatorcontrib>Neubert, Klaus</creatorcontrib><creatorcontrib>Faust, Jürgen</creatorcontrib><creatorcontrib>Ansorge, Siegfried</creatorcontrib><title>Early Phosphorylation Events Induced by DPIV/CD26-Specific Inhibitors</title><title>Cellular immunology</title><addtitle>Cell Immunol</addtitle><description>Dipeptidyl peptidase IV (DPIV, CD26) is known to be involved in the regulation of T lymphocyte and NK cell activation and proliferationin vitro.The molecular events of lymphocyte activation mediated by this ectopeptidase as well as their physiological ligands are only partly established. Particularly, the necessity of catalytic dipeptidase activity for the costimulatory function of this molecule has been controversial. Here we provide evidence for a direct involvement of DPIV/CD26 in early phosphorylation mechanisms which are known to be essential in the signal transduction cascade of human T lymphocytes. We have found that DPIV-specific inhibitors (Lys[Z(NO2)]-thiazolidide and -piperidide) are capable of inducing intracellular tyrosine phosphorylation in resting human T cells. On the other hand, both inhibitors decreased the PMA-induced tyrosine phosphorylation in human T cells in a dose-dependent manner. Furthermore, a linkage between CD26 and the tyrosine kinase p56lckwas shown by inhibition of PMA-induced hyperphosphorylation of p56lckby means of DPIV-specific inhibitors. The data presented here suggest that the inhibition of DPIV enzymatic activity induces a inhibitory signal transmitted by tyrosine kinases which leads to a block in a PMA-induced downstream pathway. These results support the assumption that DPIV/CD26 is directly involved in early processes of T cell activation via its enzymatic activity.</description><subject>Calcium - metabolism</subject><subject>CD26</subject><subject>CD3 Complex - metabolism</subject><subject>Cyclic AMP - metabolism</subject><subject>Dipeptidyl Peptidase 4 - metabolism</subject><subject>dipeptidyl peptidase IV</subject><subject>Humans</subject><subject>Lymphocyte Specific Protein Tyrosine Kinase p56(lck) - metabolism</subject><subject>Lysine - analogs & derivatives</subject><subject>Lysine - pharmacology</subject><subject>Mitogens - pharmacology</subject><subject>Phosphorylation</subject><subject>Piperidines - pharmacology</subject><subject>Protease Inhibitors - pharmacology</subject><subject>Protein Kinase C - metabolism</subject><subject>protein tyrosine phosphorylation</subject><subject>T-Lymphocytes - metabolism</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>Thiazoles - pharmacology</subject><subject>Tyrosine - metabolism</subject><issn>0008-8749</issn><issn>1090-2163</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNp1kDtPwzAUhS0EKqWwsiFlYkt6nYdjj6gtUKkSlXislmPfqEZ5FDup1H9PolZsTHf4zjnS_Qi5pxBRADbXtq4jKgSPaJJlF2RKQUAYU5ZckikA8JDnqbgmN95_A1CaCpiQicgzzkQ2JauVctUx2O5av9-17lipzrZNsDpg0_lg3ZheowmKY7Dcrr_mi2XMwvc9altaPdCdLWzXOn9LrkpVebw73xn5fF59LF7DzdvLevG0CXWSQxdmseYlJEmmDC0KxYxBXVAwKU-R5bQsUhQMMY2Z1oaWJheYK0h4xlic5oonM_J42t279qdH38naeo1VpRpsey9pToFxBkMwOgW1a713WMq9s7VyR0lBjt7k6E2O3uTobSg8nJf7okbzFz-LGjg_cRzeO1h00muLzSDHOtSdNK39b_oXAlV72A</recordid><startdate>19981010</startdate><enddate>19981010</enddate><creator>Kähne, Thilo</creator><creator>Neubert, Klaus</creator><creator>Faust, Jürgen</creator><creator>Ansorge, Siegfried</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>19981010</creationdate><title>Early Phosphorylation Events Induced by DPIV/CD26-Specific Inhibitors</title><author>Kähne, Thilo ; Neubert, Klaus ; Faust, Jürgen ; Ansorge, Siegfried</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Calcium - metabolism</topic><topic>CD26</topic><topic>CD3 Complex - metabolism</topic><topic>Cyclic AMP - metabolism</topic><topic>Dipeptidyl Peptidase 4 - metabolism</topic><topic>dipeptidyl peptidase IV</topic><topic>Humans</topic><topic>Lymphocyte Specific Protein Tyrosine Kinase p56(lck) - metabolism</topic><topic>Lysine - analogs & derivatives</topic><topic>Lysine - pharmacology</topic><topic>Mitogens - pharmacology</topic><topic>Phosphorylation</topic><topic>Piperidines - pharmacology</topic><topic>Protease Inhibitors - pharmacology</topic><topic>Protein Kinase C - metabolism</topic><topic>protein tyrosine phosphorylation</topic><topic>T-Lymphocytes - metabolism</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>Thiazoles - pharmacology</topic><topic>Tyrosine - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kähne, Thilo</creatorcontrib><creatorcontrib>Neubert, Klaus</creatorcontrib><creatorcontrib>Faust, Jürgen</creatorcontrib><creatorcontrib>Ansorge, Siegfried</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Cellular immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kähne, Thilo</au><au>Neubert, Klaus</au><au>Faust, Jürgen</au><au>Ansorge, Siegfried</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early Phosphorylation Events Induced by DPIV/CD26-Specific Inhibitors</atitle><jtitle>Cellular immunology</jtitle><addtitle>Cell Immunol</addtitle><date>1998-10-10</date><risdate>1998</risdate><volume>189</volume><issue>1</issue><spage>60</spage><epage>66</epage><pages>60-66</pages><issn>0008-8749</issn><eissn>1090-2163</eissn><abstract>Dipeptidyl peptidase IV (DPIV, CD26) is known to be involved in the regulation of T lymphocyte and NK cell activation and proliferationin vitro.The molecular events of lymphocyte activation mediated by this ectopeptidase as well as their physiological ligands are only partly established. Particularly, the necessity of catalytic dipeptidase activity for the costimulatory function of this molecule has been controversial. Here we provide evidence for a direct involvement of DPIV/CD26 in early phosphorylation mechanisms which are known to be essential in the signal transduction cascade of human T lymphocytes. We have found that DPIV-specific inhibitors (Lys[Z(NO2)]-thiazolidide and -piperidide) are capable of inducing intracellular tyrosine phosphorylation in resting human T cells. On the other hand, both inhibitors decreased the PMA-induced tyrosine phosphorylation in human T cells in a dose-dependent manner. Furthermore, a linkage between CD26 and the tyrosine kinase p56lckwas shown by inhibition of PMA-induced hyperphosphorylation of p56lckby means of DPIV-specific inhibitors. The data presented here suggest that the inhibition of DPIV enzymatic activity induces a inhibitory signal transmitted by tyrosine kinases which leads to a block in a PMA-induced downstream pathway. These results support the assumption that DPIV/CD26 is directly involved in early processes of T cell activation via its enzymatic activity.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>9758695</pmid><doi>10.1006/cimm.1998.1355</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-8749 |
ispartof | Cellular immunology, 1998-10, Vol.189 (1), p.60-66 |
issn | 0008-8749 1090-2163 |
language | eng |
recordid | cdi_proquest_miscellaneous_17106860 |
source | Elsevier |
subjects | Calcium - metabolism CD26 CD3 Complex - metabolism Cyclic AMP - metabolism Dipeptidyl Peptidase 4 - metabolism dipeptidyl peptidase IV Humans Lymphocyte Specific Protein Tyrosine Kinase p56(lck) - metabolism Lysine - analogs & derivatives Lysine - pharmacology Mitogens - pharmacology Phosphorylation Piperidines - pharmacology Protease Inhibitors - pharmacology Protein Kinase C - metabolism protein tyrosine phosphorylation T-Lymphocytes - metabolism Tetradecanoylphorbol Acetate - pharmacology Thiazoles - pharmacology Tyrosine - metabolism |
title | Early Phosphorylation Events Induced by DPIV/CD26-Specific Inhibitors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T14%3A29%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20Phosphorylation%20Events%20Induced%20by%20DPIV/CD26-Specific%20Inhibitors&rft.jtitle=Cellular%20immunology&rft.au=K%C3%A4hne,%20Thilo&rft.date=1998-10-10&rft.volume=189&rft.issue=1&rft.spage=60&rft.epage=66&rft.pages=60-66&rft.issn=0008-8749&rft.eissn=1090-2163&rft_id=info:doi/10.1006/cimm.1998.1355&rft_dat=%3Cproquest_cross%3E17106860%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17106860&rft_id=info:pmid/9758695&rfr_iscdi=true |